Search clinical trials for: NaCl 9/00

Total 2412 results

Hopital Foch

Completed

Recovery Effect of Sugammadex Measured by Bispectral and Neurosense Indices (Sugarecovery)

Anesthesia

France
University of Toronto
Diabetes Canada; Wharton Medical Clinic

Not yet recruiting

Time-restricted Eating, Window Timing, Type 2 Diabetes Status and Sex on Glycemic Control

Hyperglycemia | Obesity | Diabetes Mellitus, Type 2 | Prediabetic State

Canada
Max Dieterich
University of Rostock

Completed

Increased Microcirculation for Preventing Postoperative Wound Infections in Patients Undergoing Reduction Mammoplasty

Surgical Side Infections After Breast Reduction

Germany
Kati Järvelä
Finnish Cultural Foundation

Completed

Effects of Hypertonic Saline-HES Solution on Extracellular Water in Cardiac Surgery Patients

Fluid Volume Disorder

Finland
Hopital Foch

Terminated

Influence of Esmolol on a Closed-Loop Anesthesia System

Anesthesia

France
University of Washington
Fred Hutchinson Cancer Center

Withdrawn

The Role of GLP-1 in Satiety Perception in Humans

Obesity | Appetite Regulation

United States
Diva De Leon

Completed

Effect of Exendin-(9-39) on Fasting Adaptation and Protein Sensitivity

Congenital Hyperinsulinism

United States
Rabin Medical Center

Withdrawn

Fluids Administration During Combined Clonidine-Arginine Growth Hormone Stimulation Test

Growth Hormone Deficiency

Israel
Instituto Nacional de Enfermedades Respiratorias

Completed

Effect of Naps on Decision Making of Residents.

Sleep | Decision Making | Internship and Residency

Mexico
Mette Zander
Hvidovre University Hospital

Completed

Effect of Intact GLP-1 (7-36) and GLP-1 Metabolite (9-36) on Coronary and Peripheral Vascular Function in Adults

Coronary Microvascular Dysfunction

Denmark
National Institute of Allergy and Infectious Diseases...
Centers for Disease Control and Prevention; International AIDS Vaccine Initiative and other collaborators

Withdrawn

Safety and Effectiveness of an HIV DNA Vaccine Followed by an HIV Adenoviral Vector Vaccine for Prevention of HIV Infection in the Americas and Africa

HIV Infections
Linnaeus University
Karolinska Institutet; Region Östergötland; Kronoberg County Council; Landstinget...

Recruiting

Evaluation of the Efficiacy of Mecobalamine in the Treatment of Long-term Pain in Women Diagnosed With Fibromyalgia

Fibromyalgia

Sweden
National Institute of Allergy and Infectious Diseases...
HIV Vaccine Trials Network

Completed

Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy Adults

HIV Infections

United States
Tehran University of Medical Sciences

Unknown

Effect of N-acetylcystein in Myocardial Infarction

Acute Myocardial Infarction

Iran, Islamic Republic of
Hopital Foch

Completed

Influence of Dexmedetomidine on a Closed-Loop Anesthesia System

Anesthesia

France
Piramal Enterprises Limited

Completed

A Phase II Clinical Trial to Study the Efficacy and Safety of a New Drug P276-00 in Treatment of Recurrent and/or Locally Advanced Head and Neck Cancer (MONARCH)

Squamous Cell Carcinoma of Head and Neck

India
Piramal Enterprises Limited

Completed

Study To Evaluate Safety and Efficacy of P276-00 in Subjects With Refractory Multiple Myeloma

Relapsed and/or Refractory Multiple Myeloma

India
National Institute of Allergy and Infectious Diseases...
United States Department of Defense

Completed

Safety of and Immune Response to an HIV-1 Vaccine (VRC-HIVDNA016-00-VP) and a Vaccine Booster (VRC-HIVADV014-00-VP) in HIV Uninfected East African Adults

HIV Infections

Uganda, Kenya, Tanzania
National Institute of Allergy and Infectious Diseases...

Completed

Phase I Study of Vaccination Schedule of Experimental HIV Vaccines

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety of and Immune Response to an Adenoviral HIV Vaccine (VRC-HIVADV014-00-VP) With or Without a Plasmid HIV Vaccine (VRC-HIVDNA016-00-VP) in HIV Uninfected Adults

HIV Infections

Rwanda, Kenya
National Institute of Allergy and Infectious Diseases...
HIV Vaccine Trials Network

Completed

Safety of and Immune Response to a DNA HIV Vaccine Followed by an Adenoviral Vaccine Boost Given Three Different Ways to HIV Uninfected Adults

HIV Infections

United States, Peru
National Institute of Allergy and Infectious Diseases...

Completed

Safety, Tolerability, and Immunogenicity of the Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO), VRC-EBOADC069-00-VP, in Healthy Adults

Healthy Adult Immune Responses to Vaccine

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Immune Response to a Prime-Boost Vaccination Schedule in HIV-infected Patients

HIV

United States
Piramal Enterprises Limited

Completed

Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression (ENVER)

Melanoma

Australia, India, New Zealand
Piramal Enterprises Limited

Terminated

A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell Lymphoma

Mantle Cell Lymphoma

United States, India
Piramal Enterprises Limited

Withdrawn

Phase I Study for Safety and Efficacy of P276-00 in Subjects With Myeloma

Multiple Myeloma
National Institute of Allergy and Infectious Diseases...

Completed

"Prime-Boost" Vaccine Schedule for Prevention of HIV Infection

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents (DNA)

RNA Virus Infections | Virus Diseases | Flavivirus Infections | Flaviviridae Infections | Zika Virus Infection | Zika Virus | Flaviviral Diseases

United States, Puerto Rico, Mexico, Brazil, Colombia, Costa Rica, Ecuador, Panama, Peru
National Institute of Allergy and Infectious Diseases...

Completed

HIV-1 Vaccine Booster in Previously Immunized Uninfected Adult Volunteers

HIV Infections | Healthy

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Pharmacokinetics of VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants

HIV Infections

United States, Puerto Rico, Zimbabwe, South Africa
National Institute of Allergy and Infectious Diseases...

Completed

Safety of and Immune Response to Two Different HIV Vaccines, Each Followed by a Adenoviral Vaccine Boost, in HIV Uninfected Adults

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Trial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults

Chikungunya Virus Infection

Dominican Republic, Puerto Rico, Guadeloupe, Haiti, Martinique
National Institute of Allergy and Infectious Diseases...

Completed

Phase 1 Safety Study of Two Experimental HIV Vaccines

HIV Infections | HIV-1 | AIDS Vaccines

United States
National Institute of Allergy and Infectious Diseases...

Completed

Immune Responses to Two Experimental HIV Vaccines in Healthy Adults

Innate Immunity | HIV Negative | Adaptive Immunity

United States
National Institute of Allergy and Infectious Diseases...

Completed

Ebola and Marburg Virus Vaccines

Ebola Virus Disease | Ebola Vaccines | Marburg Virus Disease | Marburgvirus | Ebolavirus

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB080-00-AB (VRC01LS), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to Healthy Adults

Monoclonal Antibody, Human | HIV Antibodies | Neutralizing Antibody | Prevention of HIV Infection

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Phase I Study to Evaluate a Human Monoclonal Antibody (MAb) 10E8VLS Administered Alone or Concurrently With MAb VRC07-523LS Via Subcutaneous Injection in Healthy Adults

Healthy Adult Immune Response

United States
National Institute of Allergy and Infectious Diseases...
The Emmes Company, LLC; US Military HIV Research Program

Completed

Clinical Trial of Ebola Vaccines cAd3-EBO, cAd3-EBOZ and MVA-EbolaZ in Healthy Adults in Uganda

Hemorrhagic Fever, Ebola

Uganda
The Hospital for Sick Children

Terminated

Effects of Saline on Circulation in Children

Pulmonary Hypertensive Crisis

Canada
National Institute of Allergy and Infectious Diseases...

Completed

VRC 208: Dose, Safety and Immunogenicity of a Recombinant Modified Vaccinia Virus Ankara Ebola Vaccine, VRC-EBOMVA079-00-VP (MVA-EbolaZ), Administered Alone or as a Boost to cAd3-Ebola Vaccines in Healthy Adults

Healthy Adult Immune Responses to Vaccine

United States
National Institute of Allergy and Infectious Diseases...
International AIDS Vaccine Initiative

Withdrawn

Safety of and Immune Response to an HIV DNA Plasmid Vaccine Followed by HIV Adenoviral Vector Vaccine in Healthy African Adults

HIV Infections
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating Heterologous-Insert Prime-Boost HIV Vaccine Regimens in HIV-Uninfected Adults

HIV Infections

United States
Ferrer Internacional S.A.

Completed

Study to Assess the Efficacy and Safety of GF-001001-00 Cream in Secondarily-Infected Traumatic Lesions

Secondarily Infected Traumatic Lesions

Germany
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety, Pharmacokinetics, and Anti-Viral Activity of VRC01 and VRC01LS in the Serum and Mucosa of Healthy, HIV-Uninfected Adults

HIV Infections

United States, South Africa
University Hospital, Brest

Terminated

Automation Oxygen Flow Titration in Spontaneously Breathing Infants

Bronchiolitis

France
National Institute of Allergy and Infectious Diseases...
AIDS Clinical Trials Group

Completed

Phase 1, Open-label, Single Dose Study to Examine Safety, Tolerability, Pharmacokinetics and Virologic Impact of VRC01LS or VRC07-523LS in HIV-infected Viremic Adults

HIV-1

United States, Puerto Rico
Tianjin Medical University General Hospital

Recruiting

Normal Saline Infusion for Stroke After Intravenous Thrombolysis (NS-STAR)

Brain Infarct

China
Piramal Enterprises Limited

Completed

Open Label Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms

Neoplasm

Canada, India
National Institute of Allergy and Infectious Diseases...

Completed

Immune Response to an HIV DNA Plasmid Vaccine Prime Followed by Adenovirus Boost in HIV-uninfected Individuals

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Pharmacokinetics of VRC07-523LS in the Sera and Mucosae of Healthy, HIV-Uninfected Adult Participants (VRC07-523LS)

HIV Infections

United States

Search clinical trials for: NaCl 9/00

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kosovo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations